Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial

Authors:

Abstract
Malignancies represent the leading cause of death in patients infected with HIV.[1] Such individuals manifest increased incidence of both AIDS-defining cancers (e.g. Kaposi sarcoma and non-Hodgkin ...
Funding Information
  • Lymphoma Research Foundation (32954)
  • National Cancer Institute (CA180888, CA180819, CA180821, CA180820, CA180799, CA180816)

This publication has 14 references indexed in Scilit: